Science News
from research organizations

Disruption of brain-blood barrier might influence progression of Alzheimer’s

Date:
September 29, 2015
Source:
VIB - Flanders Interuniversity Institute for Biotechnology
Summary:
More and more data from preclinical and clinical studies strengthen the hypothesis that immune system-mediated actions contribute to and drive pathogenesis in Alzheimer’s disease. New insights suggest that A? indeed induces a strong inflammatory response, thereby destroying an important but often neglected brain barrier, called the blood-cerebrospinal fluid (CSF) barrier. Disruption of this blood-CSF barrier disturbs brain homeostasis and might negatively affect disease progression. Strikingly, these effects could be blocked in the presence of a matrix metalloproteinase (MMP) inhibitor.
Share:
FULL STORY

More and more data from preclinical and clinical studies strengthen the hypothesis that immune system-mediated actions contribute to and drive pathogenesis in Alzheimer's disease. The team of Roosmarijn Vandenbroucke in the Claude Libert Group (VIB/UGent) combined their knowledge and expertise related to inflammation with the expertise in Alzheimer's disease present in the Bart De Strooper Group (VIB/KU Leuven).

This collaboration lead to the insights that Aβ indeed induces a strong inflammatory response, thereby destroying an important but often neglected brain barrier, called the blood-cerebrospinal fluid (CSF) barrier. Disruption of this blood-CSF barrier disturbs brain homeostasis and might negatively affect disease progression. Strikingly, these effects could be blocked in the presence of a matrix metalloproteinase (MMP) inhibitor.

Roosmarijn Vandenbroucke: "Although further research is needed, these data suggest that blocking MMP activity or upstream inflammatory signalling, might have therapeutic potential to treat Alzheimer's disease. It is important we could demonstrate the role of the blood-cerebrospinal fluid barrier, because this would be an easier target to reach in comparison with the targets of current therapies."

Barriers Between Blood and CSF, Brain Yield to Aβ -- Not a Bad Thing?

The barrier between the blood and central nervous system crumbles in Alzheimer's disease, but researchers have known little about how this happens, or what it does to brain pathology. Two new papers shed some light on how Aβ damages the cells that protect the brain parenchyma and cerebrospinal fluid. The studies examine different systems and describe distinct mechanisms, but both add to the picture of what may happen in disease.


Story Source:

Materials provided by VIB - Flanders Interuniversity Institute for Biotechnology. Note: Content may be edited for style and length.


Cite This Page:

VIB - Flanders Interuniversity Institute for Biotechnology. "Disruption of brain-blood barrier might influence progression of Alzheimer’s." ScienceDaily. ScienceDaily, 29 September 2015. <www.sciencedaily.com/releases/2015/09/150929070234.htm>.
VIB - Flanders Interuniversity Institute for Biotechnology. (2015, September 29). Disruption of brain-blood barrier might influence progression of Alzheimer’s. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/09/150929070234.htm
VIB - Flanders Interuniversity Institute for Biotechnology. "Disruption of brain-blood barrier might influence progression of Alzheimer’s." ScienceDaily. www.sciencedaily.com/releases/2015/09/150929070234.htm (accessed May 23, 2017).

RELATED STORIES